Back to search results
NCT05814653

A Study to Evaluate Primary Care Treatment for Adolescent Eating Disorders

Enrolling by Invitation
NAAges 7–18InterventionalTreatment
Mayo Clinic
~200 participants
Updated 2026-02-05 on ClinicalTrials.gov
What's tested:Family Based Treatment-Primary CareFamily-Based Treatment

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of recruitment across 3 years
Measured over Rate of recruitment at end of study (3 years)
+3 more outcomes measured

Conditions

Eating Disorders

Explore related trials

Anorexia NervosaEating DisorderOther Specified Feeding or Eating Disorder

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Jocelyn Lebow, PhD, LP · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of a DSM-5 restrictive eating disorder (anorexia nervosa or other specified feeding or eating disorder characterized by dietary restriction and/or weight loss or failure to make expected weight gains).
Eligible patients will have at least one caregiver who is also willing to participate in the study.
Eligible patients must receive primary care through the MCHS

Exclusion

Patients will be excluded who have received FBT in the past, and/or who report active suicidality.
Patients who become physically or psychiatrically unstable during the study will be re-evaluated and referred for appropriate treatment.
Patients will be excluded if their enrolled caregiver has active substance dependence, mental health concerns that make it difficult to engage in treatment, or are perpetrators of abuse.

What this trial measures

  • Rate of recruitment across 3 yearsRate of recruitment at end of study (3 years)

    Recruitment rate will be tracked, with a goal of enrollment of 75% of eligible participants.

  • Rate of retention across 3 yearsRate of retention at end of study (3 years)

    Retention rate will be tracked, with a target retention rate (attendance at \>80% of sessions) of 70%.

  • Mixed methods feedback survey at end of treatment (caregiver/patient)Assessed after the final session (within 6 months)

    This is a unique survey with quantitative (Likert scale rating/ yes/no questions) and qualitative (short answer) questions that assesses treatment satisfaction, acceptability of session frequency, length, and therapeutic alliance, as well as comfort and familiarity with treatment intervention components. Higher scores on Likert scales indicate greater satisfaction/acceptability.

  • Rate of retention across 3 yearsRate of retention at end of study (3 years)

    Rate of retention (defined as attendance at \> 80% of sessions) will be tracked, with a target of \<30% attrition.